A SMAD4 mutation indicative of juvenile polyposis syndrome in a family previously diagnosed with Menetrier's disease

2016 ◽  
Vol 48 (10) ◽  
pp. 1255-1259 ◽  
Author(s):  
James K. Burmester ◽  
Lauren N. Bell ◽  
Deanna Cross ◽  
Patrick Meyer ◽  
Steven H. Yale
2021 ◽  
pp. 978-978
Author(s):  
Nicole B. Leonard ◽  
Mary P. Bronner

To advance the diagnostic accuracy of juvenile polyposis syndrome, an important yet often difficult diagnosis, we describe in detail a new and medically significant presentation. This hereditary and high-risk GI cancer syndrome is often associated with hereditary hemorrhagic telangiectasia, as in this 47-year-old female patient with a <i>SMAD4</i> germline pathogenic mutation. Total gastrectomy revealed giant gastric folds with inflamed foveolar hyperplasia consuming most of the gastric cardia and body but sparing the antrum. Together, this gross and histologic pathology mimics Ménétrier’s disease, an exceedingly rare and acquired protein-losing hypertrophic gastropathy. Classical gastric juvenile polyposis almost always and principally involves the antrum with multiple distinctive inflammatory <i>polyps</i> rather than the newly illustrated <i>giant gastric folds</i> of this case. No reports of giant gastric folds in juvenile polyposis have appeared in the literature. The distinction between juvenile polyposis and Ménétrier’s disease is essential due to their disparate clinical outcomes and management. The differential considerations for giant gastric folds and inflamed gastric foveolar hyperplasia are fully reviewed. On the basis of this report, the differential for giant gastric folds must now expand to include juvenile polyposis syndrome. Genetic testing for pathogenic germline mutations of the 2 known causative genes of this syndrome, namely <i>SMAD4</i> and <i>BMPR1A</i>, are readily available and should become part of the evaluation of giant gastric folds, particularly in view of the neoplastic and hereditary aspects of juvenile polyposis syndrome.


2012 ◽  
Vol 24 (8) ◽  
pp. 988-994 ◽  
Author(s):  
Verena Schwetz ◽  
Sabine Uhrig ◽  
Ekkehard Spuller ◽  
Andrea Deutschmann ◽  
Christoph Högenauer

2020 ◽  
Vol 13 (6) ◽  
pp. 1096-1101
Author(s):  
Yusuke Hashimoto ◽  
Koji Yokoyama ◽  
Hideki Kumagai ◽  
Yuko Okada ◽  
Takanori Yamagata

2018 ◽  
Vol 113 (Supplement) ◽  
pp. S850
Author(s):  
Jack Scolaro ◽  
Deena Kapadia ◽  
Houssam Kharrat ◽  
Vani Thirumala ◽  
Seshadri Thirumala

2020 ◽  
Vol 158 (6) ◽  
pp. S-1017-S-1018
Author(s):  
Sargoel Rezanejad ◽  
Marisol A. Ramirez ◽  
Qi Liu ◽  
Robert J. Coffey ◽  
Won Jae Huh

1960 ◽  
Vol 39 (3) ◽  
pp. 347-350 ◽  
Author(s):  
Earl E. Gambill ◽  
Donald C. Campbell ◽  
Donald C. Balfour ◽  
John M. Waugh ◽  
Malcolm B. Dockerty

2020 ◽  
Vol 13 (12) ◽  
pp. e236855
Author(s):  
Wendy Chang ◽  
Patricia Renaut ◽  
Casper Pretorius

Juvenile polyposis syndrome (JPS) and hereditary haemorrhagic telangiectasia (HHT) are rare autosomal dominant diseases, where symptoms manifest at childhood. A 32-year-old man with no family history of JPS or HHT with SMAD4 gene mutation who developed signs and symptoms only at the age of 32, when he was an adult. In this article, we highlight the steps taken to diagnose this rare pathology, explain its pathophysiology and management.


2001 ◽  
Vol 69 (4) ◽  
pp. 704-711 ◽  
Author(s):  
Xiao-Ping Zhou ◽  
Kelly Woodford-Richens ◽  
Rainer Lehtonen ◽  
Keisuke Kurose ◽  
Micheala Aldred ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document